An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2
An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2
复制标题
DOI:
10.1097/mbp.0000000000000086
复制
发表时间:
2015-02-01
影响因子:
1.3
通讯作者:
Shennan, Andrew H.
中科院分区:
文献类型:
--
作者:
Nathan, Hannah L.;de Greeff, Annemarie;Shennan, Andrew H.
Objectives To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting.Methods Prospective validation according to the British Hypertension Society protocol. A total of 45 pregnant women were recruited from Kimberley Hospital (South Africa), of whom 15 had pre-eclampsia.Results The Microlife 3AS1-2 device achieved an overall B/A grade in pregnancy (including pre-eclampsia), passing the British Hypertension Society protocol requirements and achieving the International Organization for Standardization standard with a mean difference and SD of -3.8 +/- 7.3 and -1.5 +/- 6.2 mmHg for systolic and diastolic pressures, respectively.Conclusion The Microlife 3AS1-2 device can be recommended for use in pregnancy, including pre-eclampsia. In addition, it fulfils the requirements stipulated by the WHO for an automated blood pressure device suitable for use in a low-resource setting. This makes it the ideal device for antenatal clinics and primary healthcare facilities in low-income and middle-income countries. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.